{"id":"76cbc9a5-8f6d-42be-916f-88344289b6ef","name":"BrainQ","slug":"brainq","description":"BrainQ is an Israeli neurotechnology company developing AI-powered, non-invasive electromagnetic therapy for stroke recovery. Its [BrainQ BCI](/models/brainq-non-invasive-bci) device delivers frequency-tuned electromagnetic stimulation to enhance brain recovery after ischemic stroke. The EMAGINE pivotal trial is enrolling 150 patients across 20 US clinical sites.","status":"private","founded":null,"hq":"Israel","hqLat":30.8124247,"hqLng":34.8594762,"hqGeocodedAt":"2026-08-23T21:34:02.460Z","hqAddress":null,"hqPrecision":null,"website":"brainqtech.com","fundingTotal":"40000000","type":"both","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://brainqtech.com/","title":"BRAIN.Q: AI-Powered Noninvasive Solution for Stroke Recovery","sourceName":"BrainQ"},{"url":"https://www.prnewswire.com/news-releases/brainq-gets-fda-breakthrough-status-for-its-device-for-reducing-disability-following-stroke-301226735.html","date":"2021-02-11","title":"BrainQ gets FDA Breakthrough status for its device for reducing disability following stroke","sourceName":"PR Newswire / BrainQ"}],"keyFacts":[{"label":"Type","value":"Non-invasive electromagnetic."},{"label":"Indication","value":"Stroke recovery."},{"label":"FDA Breakthrough Device (company-claimed)","value":"Feb 2021: Designation for its AI-powered electromagnetic field therapy to reduce disability after ischemic stroke, based on randomized controlled trial results."},{"label":"BQ System (company-claimed)","value":"A cloud-connected wearable for home-capable treatment. Limited to investigational use and not for sale in the U.S."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:37.870Z","updatedAt":"2026-10-13T02:44:31.320Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/brainq","url":"https://registry.deploy.report/companies/brainq","name":"BrainQ","description":"BrainQ is an Israeli neurotechnology company developing AI-powered, non-invasive electromagnetic therapy for stroke recovery. Its [BrainQ BCI](/models/brainq-non-invasive-bci) device delivers frequency-tuned electromagnetic stimulation to enhance brain recovery after ischemic stroke. The EMAGINE pivotal trial is enrolling 150 patients across 20 US clinical sites.","identifier":"76cbc9a5-8f6d-42be-916f-88344289b6ef","address":"Israel","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":[]}}}